Higher Prevalence of Periprosthetic Fractures with Ceramic on Polyethylene Hip Bearing Compared with Ceramic on Ceramic on the Contralateral Side: a Forty year Experience with Hip Osteonecrosis
Overview
Authors
Affiliations
Purpose: It is unclear whether late THA periprosthetic femoral fractures are related to a mechanical mechanism that decreases strength of the femur (for example, loosening) or to a biological problem as osteolysis. It is also unknown if ceramic on ceramic bearing couples decrease the risk of late periprosthetic fractures as a result of the absence of wear and osteolysis.
Material And Methods: We therefore asked whether the cumulative long-term fractures were different according to the couple of friction ceramic on ceramic or ceramic on polyethylene in 327 patients (654 hips) with bilateral THA (one ceramic-ceramic, and the contralateral ceramic-polyethylene) who had THA with cemented stems performed between from 1978 to 2000 for osteonecrosis.
Results: There were two intra-operative fractures (0.3%). The median follow-up was 22 years (range, 15-40 years), and at the most recent follow-up, the cumulative number of late (after 7 years of follow-up) post-operative fractures was 32 (5% of 654 hips). Fractures were unilateral, which means for the 327 patients, a 10% rate of fractures. Periprosthetic fractures increased in number with follow-up: seven fractures (1% of 654 hips) occurred within ten years of THA implantation, 20 (3%) within 20 years, 26 (4%) within 30 years, and 32 (5%) within 40 years. The risk of fracture was influenced (p < 0.001) by the bearing surfaces at the time of prosthetic implantation, low (0.3%) for ceramic on ceramic (1/32 fractures; 1/327 hips), high (10%) for ceramic on PE (31/32 fractures; 31/327 hips).
Conclusion: In summary, when the contralateral hip of the same patient is the control, after 40 years of follow-up, post-operative fractures occur 30 times more often on the side with PE cup than on the side with ceramic/ceramic bearing.
van Loon J, de Graeff J, Sierevelt I, Opdam K, Poolman R, Kerkhoffs G Arch Bone Jt Surg. 2022; 10(11):916-936.
PMID: 36561219 PMC: 9749123. DOI: 10.22038/ABJS.2022.59354.2933.
Total hip arthroplasty for sickle cell osteonecrosis: guidelines for perioperative management.
Hernigou P, Housset V, Pariat J, Dubory A, Flouzat Lachaniette C EFORT Open Rev. 2020; 5(10):641-651.
PMID: 33204507 PMC: 7608517. DOI: 10.1302/2058-5241.5.190073.
Zajonz D, Lang N, Ponick C, Edel M, Mobius R, Busse H Eur J Trauma Emerg Surg. 2019; 47(1):211-216.
PMID: 31520158 DOI: 10.1007/s00068-019-01222-1.
Hip osteonecrosis: stem cells for life or behead and arthroplasty?.
Hernigou P, Daltro G, Hernigou J Int Orthop. 2018; 42(7):1425-1428.
PMID: 29934715 DOI: 10.1007/s00264-018-4026-4.
Hernigou P, Thiebaut B, Housset V, Bastard C, Homma Y, Chaib Y Int Orthop. 2018; 42(7):1593-1598.
PMID: 29696307 DOI: 10.1007/s00264-018-3953-4.